Baskin Financial Services Inc. Gt Biopharma, Inc. Transaction History

Baskin Financial Services Inc.

  • $1.22 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 23, 2023
BUY
$0.89 - $58.2 $134,705 - $8.81 Million
151,354 New
151,354 $134,000

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $96.4M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Baskin Financial Services Inc. Portfolio

Follow Baskin Financial Services Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baskin Financial Services Inc., based on Form 13F filings with the SEC.

News

Stay updated on Baskin Financial Services Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email